DDrare: Database of Drug Development for Rare Diseases

Allogeneic mesenchymal stem cells (allomsc) (DrugBank: -)

2 diseases

ID	Disease name (Link within this page)	Number of trials
51	Scleroderma	1
53	Sjogren syndrome	1

51. Scleroderma [ 466 clinical trials, 536 drugs, (DrugBank: 142 drugs), 110 drug target genes, 210 drug target pathways]

Searched query = "Scleroderma", "Systemic sclerosis", "SSc", "dcSSc", "lcSSc"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 466 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00962923 (ClinicalTrials.gov)	August 2009	19/8/2009	Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)		Systemic Sclerosis;Mesenchymal Stem Cells	Biological: Allogeneic Mesenchymal Stem Cells (AlloMSC)	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	NULL	Recruiting	15 Years	65 Years	Both	20	Phase 1;Phase 2	China

53. Sjogren syndrome [ 234 clinical trials, 270 drugs, (DrugBank: 85 drugs), 49 drug target genes, 174 drug target pathways]

Searched query = "Sjogren syndrome", "Sjögren syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 234 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00953485 (ClinicalTrials.gov)	June 2009	4/8/2009	Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)	Clinical Trial of Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome - Phase ?/?	Sjogren's Syndrome;Mesenchymal Stem Cells	Biological: Allogeneic Mesenchymal Stem Cells (AlloMSC)	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	NULL	Recruiting	15 Years	70 Years	Both	20	Phase 1;Phase 2	China